Country: New Zealand
Language: English
Source: Ministry for Primary Industries
pimobendan
Dechra Veterinary Products NZ Limited
pimobendan 5.73 g/kg
Cardiovascular agent
2018-05-25
PRODUCT NAME: CARDISURE FLAVOURED TABLETS FOR DOGS COMPANY Eurovet_Dechra Veterinary Products PACK SIZES: All tablet strengths (1.25 mg, 2.5 mg, 5.0 mg and 10.0 mg) DATE: 08 th February 2024 Text above this line or in italics between parallel lines is not included in the label copy. Page 1 of 5 All tablet strengths – CARTON FRONT PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CARDISURE FLAVOURED 1.25 [2.5, 5, 10]MG TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains 1.25 [2.5, 5.0, 10.0] mg pimobendan FOR THE TREATMENT OF CANINE CONGESTIVE HEART FAILURE ORIGINATING FROM VALVULAR INSUFFICIENCY (MITRAL AND/OR TRICUSPID REGURGITATION) OR DILATED CARDIOMYOPATHY (DCM). FOR THE TREATMENT OF PRECLINICAL DCM IN LARGE BREEDS. WHEN USED IN CASES OF PRECLINICAL DCM IN LARGE BREED DOGS, PIMOBENDAN SIGNIFICANTLY PROLONGED THE TIME TO THE ONSET OF CHF OR SUDDEN DEATH, AND ALSO RESULTED IN PROLONGATION OF THE TIME TO DEATH DUE TO ALL CAUSES. DOBERMAN PINSCHER DOGS WITH PRECLINICAL DCM TREATED WITH PIMOBENDAN ALSO DEMONSTRATED A SIGNIFICANT REDUCTION IN LEFT VENTRICULAR INTERNAL DIAMETER IN BOTH SYSTOLE AND DIASTOLE (LVIDS/D) IN RESPONSE TO THERAPY. CONTENTS 20, 25, 40, 50, 80, 100, 250 TABLETS PRODUCT NAME: CARDISURE FLAVOURED TABLETS FOR DOGS COMPANY Eurovet_Dechra Veterinary Products PACK SIZES: All tablet strengths (1.25 mg, 2.5 mg, 5.0 mg and 10.0 mg) DATE: 08 th February 2024 Text above this line or in italics between parallel lines is not included in the label copy. Page 2 of 5 All tablet strengths – CARTON BACK PANEL READ THE ENCLOSED LEAFLET FOR FULL INSTRUCTIONS DIRECTIONS FOR USE: DOSAGE AND ADMINISTRATION: The tablets should be administered orally at a dose range of 0.1 mg to 0.3 mg pimobendan/kg bodyweight twice daily. The ideal dose is 0.25 mg pimobendan/ kg bodyweight twice daily, administered 12 hours apart. Each dose should be administered on an empty stomach, and at least one hour before feeding. The maintenance dose should be individually adjusted according t Read the complete document